Form 4: Acadia Healthcare CEO Christopher H. Hunter Reports Acquisition of Shares
SEC Form 4
Christopher H. Hunter, CEO of Acadia Healthcare Company, Inc., reports acquiring shares of common stock based on performance vesting restricted stock units.
Summary
- On February 28, 2024, Christopher H. Hunter, the CEO of Acadia Healthcare Company, Inc., acquired 19,822 shares of common stock at $0.00 based on 2023 performance under performance vesting restricted stock units awarded on April 11, 2022.
- He also acquired 24,269 shares of common stock at $0.00 based on 2023 performance under performance vesting restricted stock units awarded on May 9, 2023.
- Following these transactions, Hunter directly owns 95,828 shares of Acadia Healthcare Company, Inc.
- The shares will not be issued until the end of the three-year period under the restricted stock unit award.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The CEO acquiring shares based on performance is a good sign, indicating confidence in the company's future. However, it's a routine filing related to previously awarded compensation.
Positives
- The CEO's acquisition of shares, even at $0.00, signals confidence in the company's performance and future prospects.
Future Outlook
The shares acquired are subject to a three-year vesting period, indicating a long-term commitment from the CEO.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It reflects the alignment of executive incentives with company performance.
Comparison to Industry Standards
- Executive compensation packages often include performance-based equity awards to incentivize executives to achieve specific company goals.
- The vesting period of three years is a standard practice for restricted stock units.
- Comparing Hunter's total share ownership to that of CEOs at similar healthcare companies (e.g., Universal Health Services, HCA Healthcare) could provide context on the magnitude of his stake.
Stakeholder Impact
- The CEO's increased stake in the company could positively influence shareholder confidence.
- Employees may view the CEO's stock acquisition as a positive sign of company performance and stability.
Key Dates
| Date | Description |
|---|---|
| April 11, 2022 | Date of award for performance vesting restricted stock units related to the acquisition of 19,822 shares. |
| May 9, 2023 | Date of award for performance vesting restricted stock units related to the acquisition of 24,269 shares. |
| February 28, 2024 | Date of transaction for the acquisition of shares. |
| March 01, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.